Serum-adenosin deaminase as a parameter for the disease activity in sarcoidosis:;Die Serum-Adenosindesaminase als Aktivitatsparameter der Sarkoidose

Pneumologie

Volumn 53, Issue 7, 1999, Pages 323-328

  Wetzel, E ^a   Muller Quernheim J ^c   Lorenz, J ^b  

^a Innere Abteilung   (Germany)

^b Innere Abteilung   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 2 RECEPTOR; NEOPTERIN; BIOLOGICAL MARKER;

ACUTE DISEASE; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SARCOIDOSIS; THORAX RADIOGRAPHY; BLOOD; ENZYMOLOGY; REFERENCE VALUE;

ACUTE DISEASE; ADENOSINE DEAMINASE; ADULT; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; REFERENCE VALUES; SARCOIDOSIS;

EID: 0032839002     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 1 Baganha MF, Pêgo A, Lima MA, Gaspar EV, Cordeiro AR. Serum and pleural adenosine deaminase: correlation with lymphocytic populations. Chest 1990; 97: 605-610
2. 2 Chiang CS, Chiang CD, Lin JW, Chu JJ. Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effuions. Respiration 1994; 61: 150-154
3. 3 Concensus conference. Activity of sarcoidosis. Eur Respir J 1994; 7:624-627
4. 4 Daddona PE. Human adenosine deaminase: Properities and turnover in cultured T and B-Lymphoblasts. J Bio Chem 1981; 256: 12496-12501
5. 5 Dong RP, Kameoka J, Hegen M, Tanaka T, Xu, Y, Schlossman SF, Morimoto C. Characterisation of adenosin deaminase binding to human CD26 an T cells and its biologic role in immune response. J Immunol 1996; 156: 1349-1355
6. 6 Fischer D, Weyden van der MB, Snyderman R, Kelley WN. A role of adenosine deaminase in human monocyte maturation. J Clin Invest 1976; 58: 399-407
7. 7 Gakis C, Calla GM, Ortu AR, Contu A. Serum and adenosine deaminase activity: correct interpretation of the findings. Chest 1991; 99: 1555-1556
8. 8 Giblett EL, Anderson JE, Cohen F, Pollara B, Meuwissen H. Adenosine deaminase deficiency in two patients with severelly impaired cellular immunity. Lancet 1972; 2: 1067-1069
9. 9 Gilbert S, Steinbrech DS, Landas SK, Hunninghake GW. Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis 1993; 148: 483-486
10. 10 Giusti G. Adenosine deaminase. In: Bergmeyer, HU (ed.). Methods of enzymatic analyses. New York: Academic Press; 1974. 1092-1099
11. 11 Hirschhorn R, Ratech H. Isoenzymes of adenosine deaminase. In: Rattazzi, MC, Scandallios JG, Whitt GS (eds.):. Isoenzymes: Current topics in biological and medical research. New York: Alan R Liss; 1980; vol 4: 132-157
12. 12 Homolka J, Lorenz J. Zuchold HD, Müller-Quernheim J. Evaluation of soluble CD14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis. Clin Invest 1992; 70: 909-916
13. 13 Hovi T, Smyth JF, Allison AC, Williams SC. Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol 1976; 23: 395-403
14. 14 Kelbel C, Stumpf B, Schmidt W, Wetzel E, Lorenz J. Die Rolle der Serum-Adenosindeaminase als Immunparameter der Tuberkulose. Pneumologie 1995; 49: 684-688
15. 15 Klockars M, Pettersson T, Selroos O, Weber T. Activity of adenosine deaminase in sarcoidosis. Clin Chem 1985; 31: 155
16. 16 Mañá J, Orts J, Fuentes J, Badrinas F. Serum adenosine deaminase assay in sarcoidosis has little clinical usefulness. Clin Chem 1986; 32: 1429-1430
17. 17 Mañá J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: A multivariate analysis of 193 cases. Respiration 1994; 61: 219-225
18. 18 Müller-Quernheim J. Klinische und immunbiologische Betrachtungen zur entzündlichen Aktivität der Sarkoidose. Pneumologie 1996; 50: 40-48
19. 19 Müller-Quernheim J, Pfeifer S, Strausz J, Ferlinz R. Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am Rev Respir Dis 1991; 144: 1322-1329
20. 20 Nagasawa H, Uchiyama K, Yuhashi Y, Ishii S, Tamari M, Tai H., Okano H. Adenosine deaminase activity in serum and bronchoalveolar lavage fluid of patients with sarcoidosis. Sarcoidosis 1991; 8: 149
21. 21 Ocaña I, Martinez-Vazques JM, Segura RM, Fernandez de Sevilla T, Capdevila JA. Adenosine deaminase in pleural fluids: test for tuberculosis pleural effusions. Chest 1983; 84: 51-53
22. 22 Pettersson T, Ojala K, Weber TH. Adenosine deaminase in the diagnosis of pleural effusions. Acta Med Scan 1984; 15: 299-304
23. 23 Pforte A, Brunner A, Gais P, Burger G, Breyer G, Ströbel M, Häussinger K, Ziegler-Heitbrock HWL. Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis. Am Rev Respir Dis 1993; 147; 712-722
24. 24 Schmidt M, Wirtz H. Sarkoidose der Lunge: Klinischer Verlauf und entzündliche Aktivität. Pneumologie 1995; 49: 226-232
25. 25 Shore A, Dorsch HM, Gefland W. Role of adenosine deaminase in the early stages of precursor T cell maturation. Clin Exp Immunol 1981; 44: 152-155
26. 26 Spiteri MA, Clerke SW, Poulter LW. Alveolar macrophages that T-cell responses may be crucial to tile pathogenetic outcome of pulmonary sarcoidosis. Eur Respir J 1992; 5: 394-403
27. 27 Storch H, Krüger W. Rotzsch W. Adenosine deaminase activity in plasma and blood cells of patients with haematological and autoimmune diseases. Acta Haemat 1981; 65: 183-188
28. 28 Strausz J, Müller-Quernheim J. Sezernierter interleukin-2-parameter als aktivitätsparameter der sarkoidose. Dtsch med Wschr 1989; 114: 744-749
29. 29 Taylor A. Serum adenosine deaminase activity is increased in sarcoidosis. Clin Chem 1984; 30: 499-500
30. 30 Thomas PD, Hunninghake GW. State of art: current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135: 747-760
31. 31 Ungerer JPJ, Oosthuizen HM, Bissbort SH, Vermaak WJW. Serum adenosine deaminase: lsoenzymes and diagnostic application. Clin Chem 1992; 38/7: 1322-1326
32. 32 Ziegenhagen MW, Benne UK, Zissel G, Zabel P, Schlaak M, Müller-Quernheim J. Sarcoidosis: TNF-α release from alveolar macrophages and serum level of slL-2 R are prognostic markers. Am J Respir Crit Med 1997; 156: 1586-1592